SCHEMBL15869856

SCHEMBL15869856

CCOC(=O)c1cc(-c2cc(OC(F)(F)F)ccc2Cl)n(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.46
▸ FFAR4 Q5NUL3 6/20 0.44
▸ SCN5A Q14524 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ CACNA1C Q13936 1/20 0.44
▸ ELANE P08246 2/20 0.43
▸ FFAR1 O14842 2/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ MMP2 P08253 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ MMP14 P50281 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ NOTUM Q6P988 1/20 0.39
▸ MARS1 P56192 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15869842 0.86 FAAH (0.42) FAAHMMP2MMP13MMP14GABRG2
SCHEMBL15869857 0.83 FAAH (0.49) FAAHELANEMMP2MMP13MMP14
SCHEMBL2429277 0.83 FAAH (0.60) FAAHELANEMMP2MMP13MMP14
SCHEMBL15868135 0.82 FAAH (0.44) FAAHELANEMMP2MMP13MMP14
SCHEMBL15884161 0.82 HTR2A (0.42) FAAHELANEMMP2MMP13MMP14
SCHEMBL15884059 0.77 FAAH (0.41) FAAHELANEMMP2MMP13MMP14
SCHEMBL15884043 0.77 SCN9A (0.42) FAAHELANEMMP2MMP13MMP14
SCHEMBL3435464 0.77 MAPT (0.50) FAAHMARS1NPC1RAB9ASMN1; SMN2
SCHEMBL16808954 0.77 LMNA (0.43) FAAHMMP2MMP13MMP14GABRG2
SCHEMBL2560179 0.76 MMP13 (0.55) FAAHMMP2MMP13MMP14NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9078899-B2 Pyrazolyl-based carboxamides II GRUENENTHAL GMBH (DE) 2015-07-14 — — US disclosed
US-9078899-B2 Pyrazolyl-based carboxamides II GRUENENTHAL GMBH (DE) 2015-07-14 — — US disclosed
WO-2014108336-A1 PYRAZOLYL-BASED CARBOXAMIDES II AS CRAC CHANNEL INHIBITORS Grünenthal GmbH (DE) 2014-07-17 — — WO disclosed
US-20140194452-A1 Pyrazolyl-Based Carboxamides II Grünenthal GmbH (DE) 2014-07-10 — — US disclosed
US-20140194452-A1 Pyrazolyl-Based Carboxamides II Grünenthal GmbH (DE) 2014-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194452-A1 Pyrazolyl-Based Carboxamides II AADAC, VDAC2, NLRP3 FAAH 1408/4885FFAR4 2252/4885SCN5A 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback